Chapter 34: Cancer: NaProTECHNOLOGY and Early Detection
The Medical and Surgical Practice of NaProTECHNOLOGY, 413-424, 2004
Abstract
No abstract available for this article.
Topics
RRM Methods > NaProTECHNOLOGY > Clinical OutcomesDiagnostics > Cycle Charting > Clinical UtilityDiagnostics > Cycle Charting > Biomarker CorrelationDiagnostics > Biomarker Monitoring > Cervical MucusDiagnostics > Hormone Assays > ProgesteroneDiagnostics > Hormone Assays > EstrogenMenstrual Cycle > Biomarkers > Cervical MucusMenstrual Cycle > Biomarkers > HormonalMenstrual Cycle > Disorders > AmenorrheaMenstrual Cycle > Disorders > OligomenorrheaReproductive Endocrinology > Luteal Phase > DeficiencyReproductive Endocrinology > Progesterone > PhysiologyReproductive Endocrinology > Progesterone > SupplementationReproductive Endocrinology > Estrogen > Clinical EffectsPCOS > Pathophysiology > HyperandrogenismPCOS > Treatment > PharmacologicalPCOS > Diagnosis > PhenotypesInfertility > Female Factor > Ovulatory DysfunctionBody Literacy > Education > Patient ProgramsBody Literacy > Patient Empowerment > Self-AdvocacyGeneral OB/GYN > Epidemiology > PrevalenceGeneral OB/GYN > Clinical Practice > Guidelines
Cite this article
Hilgers, T. W. (2004). Chapter 34: Cancer: NaProTECHNOLOGY and Early Detection. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 413-424.
Hilgers TW. Chapter 34: Cancer: NaProTECHNOLOGY and Early Detection. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:413-424.
Hilgers, T. W. "Chapter 34: Cancer: NaProTECHNOLOGY and Early Detection." *The Medical and Surgical Practice of NaProTECHNOLOGY*, 2004, pp. 413-424.
Keywords
Diagnosis; Biomarkers; Reproductive Health; Endometrial Cancer; Breast Cancer; Ovarian Cancer